2,2,3,3-tetramethylcyclopropane carboxamide has been researched along with dipropylacetamide in 1 studies
| Studies (2,2,3,3-tetramethylcyclopropane carboxamide) | Trials (2,2,3,3-tetramethylcyclopropane carboxamide) | Recent Studies (post-2010) (2,2,3,3-tetramethylcyclopropane carboxamide) | Studies (dipropylacetamide) | Trials (dipropylacetamide) | Recent Studies (post-2010) (dipropylacetamide) |
|---|---|---|---|---|---|
| 12 | 0 | 2 | 144 | 8 | 19 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bialer, M; Finnell, RH; Pessah, N; Wlodarczyk, B; Yagen, B | 1 |
1 other study(ies) available for 2,2,3,3-tetramethylcyclopropane carboxamide and dipropylacetamide
| Article | Year |
|---|---|
Alpha-fluoro-2,2,3,3-tetramethylcyclopropanecarboxamide, a novel potent anticonvulsant derivative of a cyclic analogue of valproic acid.
Topics: Abnormalities, Drug-Induced; Animals; Anticonvulsants; Cyclopropanes; Epilepsy; Male; Mice; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Valproic Acid | 2009 |